Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 373 entries
View as:

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years

Phase: N/A Priority: Normal
NCT ID: NCT00788151 Org: User:
Start: 09/26/08 End: 08/16/10 Due: 08/16/11

Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV

Phase: N/A Priority: Normal
NCT ID: NCT00348387 Org: User:
Start: 06/30/06 End: 12/31/08 Due: 12/31/09

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations

Phase: N/A Priority: Normal
NCT ID: NCT02908269 Org: User:
Start: 09/15/16 End: 12/09/16 Due: 12/09/17

Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam

Phase: N/A Priority: Normal
NCT ID: NCT03765437 Org: User:
Start: 01/15/19 End: 03/17/19 Due: 03/17/20

Study of Quadrivalent Influenza Vaccine Among Adults

Phase: N/A Priority: Normal
NCT ID: NCT01218646 Org: User:
Start: 10/31/10 End: 04/30/11 Due: 04/30/12

Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01622062 Org: User:
Start: 06/29/12 End: 11/14/18 Due: 11/14/19

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01629589 Org: User:
Start: 06/30/12 End: 06/30/13 Due: 06/30/14

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

Phase: N/A Priority: Normal
NCT ID: NCT03476135 Org: User:
Start: 02/27/18 End: 09/10/18 Due: 09/10/19

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic

Phase: N/A Priority: Normal
NCT ID: NCT02434822 Org: User:
Start: 04/30/15 End: 07/31/16 Due: 07/31/17

Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT06727058 Org: User:
Start: 12/09/24 End: 10/13/26 Due: 10/13/27

Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea

Phase: N/A Priority: Normal
NCT ID: NCT02864927 Org: User:
Start: 07/21/16 End: 06/12/19 Due: 06/12/20

Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03430089 Org: User:
Start: 02/22/19 End: 06/06/19 Due: 06/06/20

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT06604767 Org: User:
Start: 09/17/24 End: 03/05/26 Due: 03/05/27

Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00347958 Org: User:
Start: 08/31/06 End: 10/31/08 Due: 10/31/09

A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00953524 Org: User:
Start: 08/31/09 End: 12/31/10 Due: 12/31/11

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Phase: N/A Priority: Normal
NCT ID: NCT01732627 Org: User:
Start: 11/12/12 End: 01/17/13 Due: 01/17/14

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT02842866 Org: User:
Start: 07/15/16 End: 02/13/17 Due: 02/13/18

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02563093 Org: User:
Start: 09/30/15 End: 07/31/16 Due: 07/31/17

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

Phase: N/A Priority: Normal
NCT ID: NCT02094833 Org: User:
Start: 03/31/14 End: 11/30/16 Due: 11/30/17

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04451954 Org: User:
Start: 07/02/20 End: 09/20/21 Due: 09/20/22

Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT04936685 Org: User:
Start: 08/23/22 End: 12/26/27 Due: 12/26/28

Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT06284915 Org: User:
Start: 03/19/24 End: 10/03/25 Due: 10/03/26

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00404651 Org: User:
Start: 11/30/06 End: 07/31/08 Due: 07/31/09

Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India

Phase: N/A Priority: Normal
NCT ID: NCT01550289 Org: User:
Start: 03/31/12 End: 02/28/14 Due: 02/28/15

A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT06705140 Org: User:
Start: 11/25/24 End: 04/17/26 Due: 04/17/27